INTECH Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.63M Buy
95,330
+25,983
+37% +$2.14M 0.08% 246
2025
Q4
$5.91M Buy
69,347
+12,591
+22% +$1.03M 0.05% 312
2025
Q3
$4.41M Buy
56,756
+18,843
+50% +$1.47M 0.04% 421
2025
Q2
$2.97M Sell
37,913
-39,331
-51% -$2.93M 0.03% 547
2025
Q1
$5.6M Sell
77,244
-93,151
-55% -$6.67M 0.06% 287
2024
Q4
$12.6M Sell
170,395
-228,230
-57% -$16M 0.12% 135
2024
Q3
$26.3M Buy
398,625
+304,645
+324% +$22.1M 0.29% 62
2024
Q2
$8.68M Sell
93,980
-131,353
-58% -$11.6M 0.11% 170
2024
Q1
$21.5M Buy
225,333
+208,883
+1,270% +$17.5M 0.3% 69
2023
Q4
$1.25M Buy
16,450
+6,526
+66% +$454K 0.02% 396
2023
Q3
$688K Sell
9,924
-9,610
-49% -$772K 0.01% 524
2023
Q2
$1.84M Sell
19,534
-154,685
-89% -$13.4M 0.02% 383
2023
Q1
$14.4M Sell
174,219
-311,884
-64% -$24.5M 0.12% 234
2022
Q4
$36.3M Sell
486,103
-17,039
-3% -$1.31M 0.27% 106
2022
Q3
$41.6M Sell
503,142
-486,119
-49% -$46.8M 0.31% 87
2022
Q2
$94.1M Buy
+989,261
New +$102M 0.54% 43

Other funds holding EW

INTECH Investment Management's EW Position: Q1 2026 in Review

INTECH Investment Management increased its Edwards Lifesciences (EW) stake by 37% in Q1 2026, buying an estimated $2.14M and bringing the position to 95,330 shares worth $7.63M. The position accounts for 0.08% of the portfolio, ranked #246.

INTECH Investment Management first reported a position in EW in Q2 2022 and has held it in 16 quarters since. The position peaked at $94.1M in Q2 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • INTECH Investment Management held 95,330 shares of Edwards Lifesciences worth $7.63M as of Q1 2026.
  • INTECH Investment Management bought 25,983 Edwards Lifesciences shares in Q1 2026, an estimated $2.14M.
  • Edwards Lifesciences made up 0.08% of INTECH Investment Management's portfolio in Q1 2026, its #246 holding.
  • INTECH Investment Management first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 16 quarters since.
  • INTECH Investment Management's Edwards Lifesciences position peaked at $94.1M in Q2 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.